Abstract
OBJECTIVES--To investigate the survival of children with cancer diagnosed during 1980-91 in order to assess the impact of developments in medical care on a population basis. DESIGN--Retrospective cohort study. SETTING--Great Britain. SUBJECTS--14973 children with cancer diagnosed during 1980-91 and included in the population based National Registry of Childhood Tumours. MAIN OUTCOME MEASURES--Actuarial survival rates. RESULTS--For all cancers combined, two year survival increased from 66% to 76% between 1980-2 and 1989-91, and five year survival increased from 57% to 65% between 1980-2 and 1986-8. Significant increases in survival rates occurred among children with acute lymphoblastic leukaemia, acute nonlymphocytic leukaemia, retinoblastoma, osteosarcoma, Ewing's sarcoma, rhabdomyosarcoma, and malignant gonadal germ cell tumours. No trend in survival was seen for children with Hodgkin's disease, central nervous system tumours, neuroblastoma, or Wilms's tumour. CONCLUSIONS--Nearly two thirds of children who have cancer diagnosed can now expect to survive at least 10 years.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berthold F., Hunneman D. H., Käser H., Harms D., Bertram U., Erttmann R., Schilling F. H., Treuner J., Zieschang J. Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials. Am J Pediatr Hematol Oncol. 1991 Spring;13(1):8–13. [PubMed] [Google Scholar]
- Birch J. M., Marsden H. B. A classification scheme for childhood cancer. Int J Cancer. 1987 Nov 15;40(5):620–624. doi: 10.1002/ijc.2910400508. [DOI] [PubMed] [Google Scholar]
- Bramwell V. H., Burgers M., Sneath R., Souhami R., van Oosterom A. T., Voûte P. A., Rouesse J., Spooner D., Craft A. W., Somers R. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol. 1992 Oct;10(10):1579–1591. doi: 10.1200/JCO.1992.10.10.1579. [DOI] [PubMed] [Google Scholar]
- Chessells J. M., Bailey C. C., Richards S. MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia. Leukemia. 1992;6 (Suppl 2):157–161. [PubMed] [Google Scholar]
- Dunst J., Sauer R., Burgers J. M., Hawliczek R., Kürten R., Winkelmann W., Salzer-Kuntschik M., Müschenich M., Jürgens H. Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86. Cancer. 1991 Jun 1;67(11):2818–2825. doi: 10.1002/1097-0142(19910601)67:11<2818::aid-cncr2820671118>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Eden O. B., Hann I., Imeson J., Cotterill S., Gerrard M., Pinkerton C. R. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol. 1992 Oct;82(2):310–316. doi: 10.1111/j.1365-2141.1992.tb06423.x. [DOI] [PubMed] [Google Scholar]
- Hanawa Y., Sawada T., Tsunoda A. Decrease in childhood neuroblastoma death in Japan. Med Pediatr Oncol. 1990;18(6):472–475. doi: 10.1002/mpo.2950180607. [DOI] [PubMed] [Google Scholar]
- Hann I. M., Eden O. B., Barnes J., Pinkerton C. R. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG). Br J Haematol. 1990 Nov;76(3):359–364. doi: 10.1111/j.1365-2141.1990.tb06368.x. [DOI] [PubMed] [Google Scholar]
- Hartmann O., Pinkerton C. R., Philip T., Zucker J. M., Breatnach F. Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma. J Clin Oncol. 1988 Jan;6(1):44–50. doi: 10.1200/JCO.1988.6.1.44. [DOI] [PubMed] [Google Scholar]
- Hawkins M. M., Draper G. J., Kingston J. E. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer. 1987 Sep;56(3):339–347. doi: 10.1038/bjc.1987.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawkins M. M. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst. 1991 Nov 20;83(22):1643–1650. doi: 10.1093/jnci/83.22.1643. [DOI] [PubMed] [Google Scholar]
- Kellie S. J., De Kraker J., Lilleyman J. S., Bowman A., Pritchard J. Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group. Eur J Cancer Clin Oncol. 1988 May;24(5):903–908. doi: 10.1016/0277-5379(88)90200-3. [DOI] [PubMed] [Google Scholar]
- Mann J. R., Pearson D., Barrett A., Raafat F., Barnes J. M., Wallendszus K. R. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer. 1989 May 1;63(9):1657–1667. doi: 10.1002/1097-0142(19900501)63:9<1657::aid-cncr2820630902>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Morris Jones P. H. The late effects of cancer therapy in childhood. Br J Cancer. 1991 Jul;64(1):1–2. doi: 10.1038/bjc.1991.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naito H., Sasaki M., Yamashiro K., Takeda T., Takasugi N., Uchino J., Hata Y. Improvement in prognosis of neuroblastoma through mass population screening. J Pediatr Surg. 1990 Feb;25(2):245–248. doi: 10.1016/0022-3468(90)90410-b. [DOI] [PubMed] [Google Scholar]
- Neglia J. P., Robison L. L. The childhood cancer survivor cohort study: what can we learn? J Pediatr Oncol Nurs. 1991 Apr;8(2):59–59. doi: 10.1177/104345429100800207. [DOI] [PubMed] [Google Scholar]
- Pinkerton C. R., Hann I., Eden O. B., Gerrard M., Berry J., Mott M. G. Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study Group. Br J Cancer. 1991 Sep;64(3):583–587. doi: 10.1038/bjc.1991.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pinkerton C. R., Zucker J. M., Hartmann O., Pritchard J., Broadbent V., Morris-Jones P., Breatnach F., Craft A. E., Pearson A. D., Wallendszus K. R. Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group. Br J Cancer. 1990 Aug;62(2):319–323. doi: 10.1038/bjc.1990.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pritchard J., Stiller C. A., Lennox E. L. Overtreatment of children with Wilms' tumour outside paediatric oncology centres. BMJ. 1989 Sep 30;299(6703):835–836. doi: 10.1136/bmj.299.6703.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson C. M., Hawkins M. M., Kingston J. E. Late deaths and survival after childhood cancer: implications for cure. BMJ. 1994 Jul 16;309(6948):162–166. doi: 10.1136/bmj.309.6948.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanders B. M., Draper G. J., Kingston J. E. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol. 1988 Aug;72(8):576–583. doi: 10.1136/bjo.72.8.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sankila R., Hakama M. Survival trends for neuroblastoma patients in Finland: negative reflections on screening. Eur J Cancer. 1992;29A(1):122–123. doi: 10.1016/0959-8049(93)90588-7. [DOI] [PubMed] [Google Scholar]
- Shafford E. A., Kingston J. E., Malpas J. S., Plowman P. N., Pritchard J., Savage M. O., Eden O. B. Testicular function following the treatment of Hodgkin's disease in childhood. Br J Cancer. 1993 Dec;68(6):1199–1204. doi: 10.1038/bjc.1993.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stevens R. F., Hann I. M., Wheatley K., Gray R. Intensive chemotherapy with or without additional bone marrow transplantation in paediatric AML: progress report on the MRC AML 10 trial. Medical Research Council Working Party on Childhood Leukaemia. Leukemia. 1992;6 (Suppl 2):55–58. [PubMed] [Google Scholar]
- Stiller C. A., Bunch K. J. Trends in survival for childhood cancer in Britain diagnosed 1971-85. Br J Cancer. 1990 Nov;62(5):806–815. doi: 10.1038/bjc.1990.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stiller C. A. Centralisation of treatment and survival rates for cancer. Arch Dis Child. 1988 Jan;63(1):23–30. doi: 10.1136/adc.63.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stiller C. A., Draper G. J. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child. 1989 May;64(5):657–661. doi: 10.1136/adc.64.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stiller C. A., Eatock E. M. Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study. Arch Dis Child. 1994 Mar;70(3):219–223. doi: 10.1136/adc.70.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]